FABP5 and Miyoshi myopathy: This interplay acts as immunosuppressive mechanism during tumor progression, by which MM cells can regulate the function of immune cells, and is associated with unfavorable outcomes in patients, making FABP5 a candidate prognostic marker in MM [88].